HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes].

AbstractOBJECTIVE:
To investigate the change in serum visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes mellitus (T2DM) and to explore the relationship between visfatin insulin resistance and diabetes.
METHODS:
Thirty-three patients with Type 2 diabetes were studied before and after the gastric bypass surgery. The level of fasting serum visfatin was measured by enzyme-linked immunosorbent assay. Fasting plasma glucose (FPG), glycated hemoglobin (HbA1c) and fasting insulin (FINS) were measured before and after the gastric bypass surgery.
RESULTS:
Compared with before the operation, the indicators of HbA1c, FINS, and insulin resistance index (HOMA-IR) were decreased after the laparoscopic Roux-en-Y gastric bypass surgery. The body mass index (BMI) [(24.53 ± 0.62) kg/m² vs (26.71 ± 0.69) kg/m2] was decreased, with significant difference (P<0.001). The serum visfatin level [(9.79 ± 0.64) ng/mL] was significantly lower than before the operation [(38.24 ± 5.32) ng/mL], with significant difference (P<0.001).
CONCLUSION:
Serum level of visfatin is decreased in T2DM patients who undergo gastric bypass surgry, reflecting an improvement in insulin resistance and diabetes.
AuthorsYiqun Liu, Jing Xiong, Honghui He, Shaihong Zhu, Zhaohui Mo
JournalZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences (Zhong Nan Da Xue Xue Bao Yi Xue Ban) Vol. 38 Issue 3 Pg. 258-61 (Mar 2013) ISSN: 1672-7347 [Print] China
PMID23545832 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Nicotinamide Phosphoribosyltransferase
Topics
  • Diabetes Mellitus, Type 2 (blood, surgery)
  • Female
  • Gastric Bypass
  • Humans
  • Insulin Resistance
  • Laparoscopy
  • Male
  • Middle Aged
  • Nicotinamide Phosphoribosyltransferase (blood)
  • Postoperative Period

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: